中国临床试验注册和发表机制及实施说明
Statement for Chinese Clinical Trial Registration and Publishing System
出处
《第二军医大学学报》
CAS
CSCD
北大核心
2006年第7期701-702,共2页
Academic Journal of Second Military Medical University
关键词
临床试验
中国
注册
发表
clinical trials
China
registration
publish
参考文献4
-
1卫生部新闻办公室.中国医药卫生期刊质量管理规范试行说明[EB/OL].(2004-04-02).Http://www.Moh.Gov.Cn/public/open.aspx? N_id= 3618&seq=%B0%B4%C8%BA%CB%F7%D2%FD.
-
2Health Organization International Clinical Trials Registry Platform (ICTRP)[EB/OL].http://www.who.int/ictrp/about/en/.
-
3Draft-The Ottawa Statement,Part Two:Principles of operationalisation for international trial registration[EB/OL].http://ottawagroup.ohri.ca/statement2.html.
-
4吴泰相,李幼平,姚巡,李静.实行临床试验注册制度,提高我国临床研究质量[J].中国循证医学杂志,2006,6(3):153-156. 被引量:42
二级参考文献14
-
1The WHO:International Clinical Trials Registry Platform (ICTRP).Frequently asked questions.Available from:http://www.who.int/entity/ictrp/faq/en/index.html.
-
2De Angelis C,Drazen JM,Frizelle FA,et al.Clinical trial registration:a statement from the International Committee of Medical Journal Editors.JAMA,2004;292(11):1363-1364.
-
3The ICMJE.Update on Trials Registration:October 2004.Available from:http://www.icmje.org/icmje_response.pdf.
-
4De Angelis C,Drazen JM,Frizelle FA,et al.Is This Clinical Trial Fully Registered?:A Statement from the International Committee of Medical Journal Editors.JAMA,2005; 293(23):2927-2929.
-
5The WHO.New York Statement-General Consensus of Stakeholders (28-29 October 2004).Available from:http://www.who.int/ictrp/about/details/en/index.html.
-
6Ministerial Summit on Health Research.Mexico Statement on Health Research.Available from:http://www.who.int/entity/rpc/summit/agenda/Mexico_Statement-English.pdf.
-
7Available from:http://ottawagroup.ohri.ca/background.html.
-
8Krleza-Jeric K,Chan A-W,Dickersin K,et al.for the Ottawa Group.Principles for international registration of protocol information andresults from human trials of health related interventions:Ottawa Statement(part 1).BMJ,2005;330(7497):956-958.
-
9The Ottawa Group.The Ottawa Statement,Part Two:Principles of operationalisation for international trial registration (Draft).Available from:http://ottawagroup.ohri.ca/statement2.html.
-
10The WHO:International Clinical Trials Registry Platform (ICTRP).Available from:http://www.who.int/ictrp/en/
共引文献41
-
1李幼平,姚巡.循证医学回眸与展望[J].医学与哲学(B),2006,27(5):76-79. 被引量:16
-
2吴泰相,李幼平,李静,钟紫红,贾万年.中国临床试验注册和发表机制及实施说明[J].中国循证医学杂志,2006,6(6):395-396. 被引量:21
-
3吴泰相,李幼平,李静,钟紫红,贾万年,无.中国临床试验注册和发表机制及实施说明[J].中西医结合学报,2006,4(4):333-334. 被引量:5
-
4吴泰相,李幼平,李静,钟紫红,贾万年.中国临床试验注册和发表机制及实施说明[J].解放军医学杂志,2006,31(7):741-742.
-
5吴泰相,李幼平,李静,钟紫红,贾万年.中国临床试验注册和发表机制及实施说明[J].中国中西医结合杂志,2006,26(7):586-587. 被引量:2
-
6吴泰相,李幼平,李静,钟紫红,贾万年.中国临床试验注册和发表机制及实施说明[J].中国康复理论与实践,2006,12(9):778-779. 被引量:1
-
7吴泰相,李幼平,李静,钟紫红,贾万年.中国临床试验注册和发表机制及实施说明[J].南京医科大学学报(社会科学版),2006,6(3):267-268.
-
8吴泰相,李幼平,李静,钟紫红,贾万年,无.中国临床试验注册和发表机制及实施说明[J].中国动脉硬化杂志,2006,14(7):639-640. 被引量:1
-
9李幼平,杜亮,王莉,姚巡,孙鑫.借鉴循证医学理念方法,提高我国新药审评质量[J].中国循证医学杂志,2006,6(12):851-854. 被引量:1
-
10李幼平,吴泰相,刘关键,李静,李廷谦,商洪才,张伯礼,卞兆祥,DavidMoher.中国循证医学中心促进中医药现代化的策略[J].中国循证医学杂志,2007,7(3):159-161. 被引量:31
-
1吴泰相,李幼平,李静,钟紫红,贾万年,无.中国临床试验注册和发表机制及实施说明[J].中西医结合学报,2006,4(4):333-334. 被引量:5
-
2李幼平,吴泰相,李静,钟紫红,贾万年,无.创建中国临床试验注册和发表机制的联合宣言[J].中西医结合学报,2006,4(4):331-332. 被引量:3
-
3第四届亚太地区循证医学研讨会征文通知[J].中国现代神经疾病杂志,2006,6(1):51-51.
-
4第四届亚太地区循证医学研讨会分会场[J].中国循证医学杂志,2006,6(5).
-
5第四届亚太地区循证医学研讨会会议信息[J].中国神经免疫学和神经病学杂志,2006,13(1):48-48.
-
6第四届亚太地区循证医学研讨会会议信息[J].实用医院临床杂志,2006,3(2):26-26.
-
7Register 3APFA now![J].Asian Journal of Andrology,2008,10(5):807-807.
-
82006年Kidney International改由Nature Publishing Group出版[J].中华肾脏病杂志,2005,21(3):164-164.
-
92006年Kidney International改由Nature Publishing Group出版[J].中华肾脏病杂志,2005,21(5):281-281.
-
10李幼平,吴泰相.临床试验的里程碑事件[J].中华普通外科学文献(电子版),2007,1(4):245-247.